ACADIA PHARMACEUTICALS A/S: Financial statements 2017
CVR: 19670694
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
ACADIA PHARMACEUTICALS A/S (CVR 19670694) has filed annual accounts for 2017. In 2017, the company reported a net result of DKK -73,652 compared with DKK -44,570 the year before. Equity in the 2017 report amounted to DKK -388,482.
- Profit/Loss
- DKK -73,652
- Equity
- DKK -388,482
- Total Assets
- DKK 6,868
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | - | -74 t. | -388 t. | 0 |
| 2016 | - | - | -45 t. | -315 t. | - |
| 2015 | - | - | -56 t. | -270 t. | - |
| 2014 | - | - | -147 t. | -214 t. | - |
| 2013 | - | - | -57 t. | -67 t. | - |
Official annual report
Keep an eye on ACADIA PHARMACEUTICALS A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
ACADIA PHARMACEUTICALS A/S has published its annual report for 2016. The net result was DKK -44,570.
As of May 23, 2017, Justin Thacker has joined the board of directors of ACADIA PHARMACEUTICALS A/S.
As of May 23, 2017, Todd Young has joined the board of directors of ACADIA PHARMACEUTICALS A/S.
As of May 23, 2017, Torsten Erik Rasmussen has left the board of directors of ACADIA PHARMACEUTICALS A/S.
As of May 23, 2017, Uli Alf Hacksell has left the board of directors of ACADIA PHARMACEUTICALS A/S.
As of May 23, 2017, Glenn Frederick Baity is registered as adm. dir. of ACADIA PHARMACEUTICALS A/S.
As of May 23, 2017, Uli Alf Hacksell has stepped down as adm. dir. of ACADIA PHARMACEUTICALS A/S.
About ACADIA PHARMACEUTICALS A/S
ACADIA PHARMACEUTICALS A/S is a Danish company of the type Aktieselskab based in Bagsværd, founded in 1996. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named RECEPTOR TECHNOLOGIES A/S and VICH 4861 A/S. The management consists of Jennifer Jane Rhodes. The board consists of Martin Choy (chair), James Kenji Kihara, Jennifer Jane Rhodes and Peter Francis Chae. The company is owned by Acadia Pharmaceuticals Inc.. The company has 6 employees (2005). In 2025, the company reported a net result of DKK -471,043 compared with DKK -99,365 the year before. Equity in the 2025 report amounted to DKK -1,563,180.